BRCA1 and breast cancer: Within a breast cancer biobank research study, ten germline mutations in BRCA1 (n = 5) or BRCA2 (n = 5) were incidentally revealed in study participants that were themselves not aware of their mutation carrier status, 5–7 years after they had been included in the study.